Dr. Shane Patrick Hennessy, D.O. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Plaza Dr Ste 400, Belle Vernon, PA 15012 Phone: 724-379-5816 Fax: 724-379-5813 |
Dr. L. Douglas Pepper, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 728 Broad Ave, Belle Vernon, PA 15012 Phone: 724-929-2550 Fax: 724-929-5676 |
Dr. M. Elizabeth Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 728 Broad Ave, Belle Vernon, PA 15012 Phone: 724-929-2550 Fax: 724-929-5676 |
Dr. Lauren Herchak Ayersman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Plaza Dr, Suite 290, Belle Vernon, PA 15012 Phone: 724-379-6850 Fax: 678-553-0330 |
James Locke Brooks Iii, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 118 Laurel Dr, Belle Vernon, PA 15012 Phone: 724-379-8409 |
Dr. Joanna R Swauger, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Plaza Dr, Suite 290, Belle Vernon, PA 15012 Phone: 724-379-6850 Fax: 678-553-0330 |
News Archive
TrinityCare Senior Living, Inc. (OTCBB: TCSR), which develops, manages and owns faith-based senior living facilities, today announced the execution of a $1.65 million investment agreement by RCHP, LLC, a Texas-based boutique investment firm.
Health Care Compliance Strategies, Inc. (HCCS), the leading provider of online healthcare compliance and competency training, today announced the release of a new online compliance training course designed specifically for nursing facilities including nursing homes, skilled nursing facilities and other long term care providers.
The current study reports the effective reproduction number of B.1.1.519 and presents its geographical origin based on phylogenetic analysis.
Seizures in women of childbearing age commonly show patterns of exacerbation that involve hormones as a factor. Investigators today reported the favorable outcome of a multicenter randomized, double-blinded, placebo-controlled phase III clinical trial of progesterone therapy in reducing these perimenstrually exacerbated (catamenial) seizures.
› Verified 6 days ago